A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06826313 · RECRUITING
Trial details
- NCT number
- NCT06826313
- Sponsor
- Guangzhou Virotech Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-19
- Primary completion
- 2025-12-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.